• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫功能低下的大疱性类天疱疮患者发生由紫色毛壳菌引起的致命性透明丝孢霉病伴皮肤累及。

Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid.

机构信息

Unit of Dermatology, Department of Medical Science and Public Health, University of Cagliari.

Laboratory Clinical Chemical Analysis and Microbiology University Hospital of Cagliari.

出版信息

Acta Biomed. 2021 Jul 1;92(3):e2021139. doi: 10.23750/abm.v92i3.10100.

DOI:10.23750/abm.v92i3.10100
PMID:34212928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8343759/
Abstract

Emergent pathogen as Purpureocillium lilacinum are becoming cause of morbidity and mortality in our population, especially in immunocompromised patients. We describe a case of hyalohyphomycosis in a diabetic man under systemic steroid treatment for a bullous pemphigoid. Treatment with different antimycotic drugs were ineffective and infection spread diffusely, leading to deterioration of general conditions and ultimately death. The aim of this article is to increase awareness of clinicians about this uncommon, but frequently fatal refractory mycotic infection.

摘要

新兴病原体如枝顶孢霉正在成为我们人群发病和死亡的原因,尤其是在免疫功能低下的患者中。我们描述了一例糖尿病患者在系统性类固醇治疗大疱性类天疱疮时发生的透明丝孢霉病。不同抗真菌药物的治疗均无效,感染广泛扩散,导致一般情况恶化,最终死亡。本文的目的是提高临床医生对这种不常见但经常致命的难治性真菌感染的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaae/8343759/5862eec14a20/ACTA-93-139-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaae/8343759/5862eec14a20/ACTA-93-139-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaae/8343759/5862eec14a20/ACTA-93-139-g001.jpg

相似文献

1
Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid.免疫功能低下的大疱性类天疱疮患者发生由紫色毛壳菌引起的致命性透明丝孢霉病伴皮肤累及。
Acta Biomed. 2021 Jul 1;92(3):e2021139. doi: 10.23750/abm.v92i3.10100.
2
Cutaneous infection caused by Purpureocillium lilacinum: Case reports and literature review of infections by Purpureocillium and Paecilomyces in Taiwan.紫色毛壳菌所致皮肤感染:台湾地区紫色青霉和棘孢木霉感染的病例报告和文献复习。
J Dermatol. 2023 Aug;50(8):1088-1092. doi: 10.1111/1346-8138.16806. Epub 2023 Apr 20.
3
Recurrent cutaneous hyalohyphomycosis secondary to Purpureocillium lilacinum in an immunocompetent individual.免疫功能正常个体中由淡紫拟青霉引起的复发性皮肤透明丝孢霉病。
Australas J Dermatol. 2021 Aug;62(3):e411-e413. doi: 10.1111/ajd.13657. Epub 2021 Jun 25.
4
An unusual case of hyalohyphomycosis due to in a patient with myasthenia gravis.一例重症肌无力患者发生由[未提及具体真菌名称]引起的透明丝孢霉病的罕见病例。
Curr Med Mycol. 2018 Jun;4(2):36-39. doi: 10.18502/cmm.4.2.62.
5
Cutaneous hyalohyphomycosis caused by Purpureocillium lilacinum in an immunocompetent patient: case report and review.免疫功能正常患者感染紫色毛壳菌引起的皮肤透明丝孢霉病:病例报告及文献复习。
Med Mycol. 2013 Aug;51(6):664-8. doi: 10.3109/13693786.2012.757656. Epub 2013 Jan 21.
6
Subcutaneous hyalohyphomycosis due to Purpureocillium lilacinum in an immunocompromised patient after renal transplantation.
J Dermatol. 2017 Jun;44(6):725-726. doi: 10.1111/1346-8138.13521. Epub 2016 Jul 27.
7
Purpureocillium lilacinum an emergent pathogen: antifungal susceptibility of environmental and clinical strains.紫色毛壳菌:一种新兴的病原体:环境和临床分离株的抗真菌药敏性。
Lett Appl Microbiol. 2022 Jul;75(1):45-50. doi: 10.1111/lam.13707. Epub 2022 Apr 4.
8
Purpureocillium lilacinum as unusual cause of pulmonary infection in immunocompromised hosts.紫黑炭角菌致免疫功能低下宿主肺部感染罕见。
J Infect Dev Ctries. 2020 Apr 30;14(4):415-419. doi: 10.3855/jidc.12235.
9
Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.紫色毛癣菌所致侵袭性感染:FungiScope®及文献中 101 例病例的临床特征和结局。
J Antimicrob Chemother. 2021 May 12;76(6):1593-1603. doi: 10.1093/jac/dkab039.
10
Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients.免疫抑制患者的皮肤透明丝孢霉病及其非典型临床表现
Life (Basel). 2024 Jan 21;14(1):154. doi: 10.3390/life14010154.

引用本文的文献

1
: A minireview.一篇小型综述。
World J Clin Cases. 2025 Oct 16;13(29):108582. doi: 10.12998/wjcc.v13.i29.108582.
2
Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients.免疫抑制患者的皮肤透明丝孢霉病及其非典型临床表现
Life (Basel). 2024 Jan 21;14(1):154. doi: 10.3390/life14010154.
3
Protection and Disinfection Activities of Oregano and Thyme Essential Oils Encapsulated in Poly(ε-caprolactone) Nanocapsules.包埋于聚己内酯纳米胶囊中的牛至和百里香精油的保护和消毒活性。

本文引用的文献

1
Mold infections of the central nervous system.中枢神经系统霉菌感染。
N Engl J Med. 2014 Jul 10;371(2):150-60. doi: 10.1056/NEJMra1216008.
2
Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy.利用氟磁共振波谱技术对健康成年人脑部伏立康唑浓度进行定量分析。
Antimicrob Agents Chemother. 2013 Nov;57(11):5271-6. doi: 10.1128/AAC.00394-13. Epub 2013 Aug 12.
3
Susceptibility testing and molecular classification of Paecilomyces spp.拟青霉属菌种的药敏试验及分子分类
Molecules. 2023 Jan 19;28(3):1018. doi: 10.3390/molecules28031018.
Antimicrob Agents Chemother. 2008 Aug;52(8):2926-8. doi: 10.1128/AAC.00538-08. Epub 2008 Jun 2.
4
Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections.淡紫拟青霉感染的临床表现、治疗及转归
Clin Microbiol Infect. 2006 Oct;12(10):948-60. doi: 10.1111/j.1469-0691.2006.01481.x.
5
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review.伊曲康唑成功治疗免疫功能正常宿主由淡紫拟青霉引起的皮肤透明丝孢霉病:病例报告及文献复习
Eur J Clin Microbiol Infect Dis. 1999 Nov;18(11):814-8. doi: 10.1007/s100960050407.